Immunogenicity and safety of combined measles-mumps-rubella-varicella vaccine using new measles and rubella working seeds in healthy children in Taiwan and Singapore: a phase II, randomized, double-blind trial.
Open Access
- 12 June 2013
- journal article
- research article
- Published by Taylor & Francis Ltd in Human Vaccines & Immunotherapeutics
- Vol. 9 (6), 1308-15
- https://doi.org/10.4161/hv.24035
Abstract
Aim: This study evaluated the immunogenicity and safety of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine produced with measles and rubella monovalent bulks derived from a newly established working seed virus stock (MMRVnew WS) compared with the combined MMRV vaccine derived from the current seed virus stock, in Taiwanese and Singaporean children (NCT00892775). Methods:Healthy children aged 11–22 mo were randomized to receive two doses of either the MMRV new WS vaccine or the MMRV vaccine. Antibody titers against measles, mumps and rubella were measured using ELISA and against varicella using an immunofluorescence assay. The primary objective was to demonstrate non-inferiority of MMRVnew WS to MMRV in terms of post-dose-1 seroconversion rates, defined as a group difference with a lower limit of the 95% confidence interval greater than -10% for each antigen. Parents/guardians recorded symptoms in diary cards for 43 d after each vaccine dose. Results:Non-inferiority of MMRV new WS to MMRV was achieved for all vaccine antigens. The lower limits of the 95% confidence intervals for group differences (MMRVnew WS group vs. MMRV) for measles (99.4% vs 100%), mumps (89.7% vs 90.4%), rubella (99.7% vs 100%) and varicella (97.6% vs 92.9%) seroconversion rates were greater than -10%. Mild symptoms including a peak in fever between days 5 and 12, post-dose-1, was observed in both groups. Conclusion:The immune responses elicited by the MMRV new WS vaccine were non-inferior to that elicited by the MMRV vaccine for all antigens. Both vaccines exhibited an acceptable safety profile in Taiwanese and Singaporean children.Keywords
This publication has 27 references indexed in Scilit:
- Epidemiological characteristics of varicella from 2000 to 2008 and the impact of nationwide immunization in TaiwanBMC Infectious Diseases, 2011
- Pandemic (H1N1) 2009 Encephalitis in Woman, TaiwanEmerging Infectious Diseases, 2011
- Imported Measles and Implications for Its Elimination in TaiwanEmerging Infectious Diseases, 2011
- Near Elimination of Varicella Deaths in the US After Implementation of the Vaccination ProgramPEDIATRICS, 2011
- Immunogenicity and safety of a measles–mumps–rubella–varicella vaccine following a 4-week or a 12-month interval between two dosesVaccine, 2011
- Varicella breakthrough infection and vaccine effectiveness in TaiwanVaccine, 2011
- Rubella Seroepidemiology and Catch-up Immunization among Pregnant Women in Taiwan: Comparison between Women Born in Taiwan and Immigrants from Six Countries in AsiaThe American Journal of Tropical Medicine and Hygiene, 2010
- Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care settingVaccine, 2009
- Immunogenicity and Safety Assessments After One and Two Doses of a Refrigerator-Stable Tetravalent Measles-Mumps-Rubella-Varicella Vaccine in Healthy Children During the Second Year of LifeThe Pediatric Infectious Disease Journal, 2008
- Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997-2005Archives of Disease in Childhood, 2008